Potential role of different animal models for the evaluation of bioactive compounds

Animal models are crucial in biomedical research, facilitating the understanding of human diseases at the molecular and cellular levels. At the same time, animal models aid in molecular screening for drug discovery and development. In this review article, we extensively discuss two critical points: the importance of animal models and the bioactive compounds. During the discussion of the importance of animal models, we explore how they aid in understanding disease mechanisms and progression, as well as genetic diseases, drug discovery and development, and drug repurposing. To discuss the importance of bioactive compounds, we illustrate their impact on human health and disease, as well as their industrial applications. Finally, we discuss the various studies on bioactive compounds that have been conducted using different animal models. To highlight the various studies on bioactive compounds using animal models, we categorized them under two headings: mammalian animal models and non-mammalian animal models. Again, for mammalian animal models, we explained various studies on bioactive compounds in mice, rats, rabbits, guinea pigs, hamsters, ferrets, and gerbils. Similarly, for non-mammalian animal models, we illustrated the different studies on bioactive compounds using zebrafish, <i>Drosophila melanogaster</i>, and <i>Caenorhabditis elegans</i>. The work will be beneficial in various ways in the field. First, using animal models, researchers can develop effective next-generation therapies for a number of human diseases utilizing bioactive compounds. Second, during drug development using bioactive compounds, researchers can assess the efficacy, safety, and pharmacokinetics of these compounds in an animal model. Third, the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of these bioactive compounds can be studied in animal models before clinical trials. Ultimately, the scientific combination between bioactive compounds and animal models will facilitate the advancement of scientific and biomedical discoveries implicating bioactive compounds.

Authors

Institutions

Publication Details

Journal
Annals of Medicine and Surgery
Published
2025-09-29
DOI
https://doi.org/10.1097/ms9.0000000000003860
Primary Topic
Biochemical effects in animals
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Potential role of different animal models for the evaluation of bioactive compounds

Manojit Bhattacharya, Anirban Debnath, Chiranjib Chakraborty, A. P. Das
Annals of Medicine and Surgery
Biochemical effects in animals
article

Potential role of different animal models for the evaluation of bioactive compounds

Manojit Bhattacharya, Anirban Debnath, Chiranjib Chakraborty, A. P. Das
article en

Abstract

Animal models are crucial in biomedical research, facilitating the understanding of human diseases at the molecular and cellular levels. At the same time, animal models aid in molecular screening for drug discovery and development. In this review article, we extensively discuss two critical points: the importance of animal models and the bioactive compounds. During the discussion of the importance of animal models, we explore how they aid in understanding disease mechanisms and progression, as well as genetic diseases, drug discovery and development, and drug repurposing. To discuss the importance of bioactive compounds, we illustrate their impact on human health and disease, as well as their industrial applications. Finally, we discuss the various studies on bioactive compounds that have been conducted using different animal models. To highlight the various studies on bioactive compounds using animal models, we categorized them under two headings: mammalian animal models and non-mammalian animal models. Again, for mammalian animal models, we explained various studies on bioactive compounds in mice, rats, rabbits, guinea pigs, hamsters, ferrets, and gerbils. Similarly, for non-mammalian animal models, we illustrated the different studies on bioactive compounds using zebrafish, <i>Drosophila melanogaster</i>, and <i>Caenorhabditis elegans</i>. The work will be beneficial in various ways in the field. First, using animal models, researchers can develop effective next-generation therapies for a number of human diseases utilizing bioactive compounds. Second, during drug development using bioactive compounds, researchers can assess the efficacy, safety, and pharmacokinetics of these compounds in an animal model. Third, the ADMET (absorption, distribution, metabolism, excretion, and toxicity) properties of these bioactive compounds can be studied in animal models before clinical trials. Ultimately, the scientific combination between bioactive compounds and animal models will facilitate the advancement of scientific and biomedical discoveries implicating bioactive compounds.

Annals of Medicine and SurgeryVol. 87(11)
Fakir Mohan University (IN), Adamas University (IN)
Openalex Percentile: Top 65%
Biochemical effects in animals
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.